Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/1999
06/09/1999EP0920319A1 Antagonists of gonadotropin releasing hormone
06/09/1999EP0920306A2 Chemokine receptor antagonists and methods of use therefor
06/09/1999EP0920253A1 Il-8 receptor antagonists
06/09/1999EP0763012B1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
06/09/1999EP0748321B1 Process for the preparation of an indazole-3-carboxamide derivative
06/09/1999CN1219172A Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
06/09/1999CN1218802A Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
06/09/1999CN1218689A Chinese drug preparation for curing hepatopathy and its preparation
06/08/1999US5910592 Substituted thiazolidinedione derivatives
06/08/1999US5910574 Human trk receptors and neurotrophic factor inhibitors
06/08/1999CA2242308A1 Novel compounds
06/08/1999CA1340589C Therepeutic nucleosides
06/03/1999WO1999027111A1 Desaturase genes and their use
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999026959A1 NOVEL recJ
06/03/1999WO1999026945A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS
06/03/1999WO1999026942A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
06/03/1999WO1999026924A1 Substituted oximes as neurokinin antagonists
06/03/1999WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
06/03/1999WO1999026909A2 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026642A1 Use of the e.coli strain dsm 6601 for treating diarrhoea in veterinary medicine
06/03/1999WO1999026631A1 Methods for treating postmenopausal women using ultra-low doses of estrogen
06/03/1999WO1999026628A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999WO1999026624A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours
06/03/1999WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
06/03/1999WO1999026615A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999WO1999013894A3 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/03/1999WO1999010312B1 N-alkanoylphenylalanine derivatives
06/03/1999WO1999007729A3 Peptides having potassium channel opener activity
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311472A1 Desaturase genes and their use
06/03/1999CA2311129A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours
06/03/1999CA2310773A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
06/03/1999CA2310401A1 Alpha-hydroxy, -amino and -halo derivatives of beta-sulfone hydroxamates as matrix metalloproteinase inhibitors
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors
06/03/1999CA2309338A1 Cyclic amino acid derivatives as cell adhesion inhibitors
06/03/1999CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists
06/02/1999EP0919245A2 NK-1 receptor antagonist and a systemic antiinflammatory corticosteroid for the treatment of emesis
06/02/1999EP0918864A2 PROTEINS, IN PARTICULAR MEMBRANE PROTEINS, OF $i(HELICOBACTER PYLORI), THEIR PREPARATION AND USE
06/02/1999EP0918857A1 Human induced tumor protein
06/02/1999EP0918797A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH $g(a)4$g(b)7 INTEGRIN
06/02/1999EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor
06/02/1999EP0918754A1 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents
06/02/1999EP0918544A2 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect
06/02/1999EP0918528A1 Method for treating gastrointestinal damage
06/02/1999EP0918526A1 Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
06/02/1999EP0667854B1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
06/02/1999EP0630376B1 Condensed indole derivatives as 5-ht4-receptor antagonists
06/02/1999EP0625138B1 Novel amidine derivatives, their preparation and their use as medicaments with ltb4 antagonistic effect
06/02/1999EP0548254B1 6- or 7-(imidazolidin-2-ylideneamino)-1,4-benzoxazines as alpha adrenergic agents
06/02/1999CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
06/02/1999CN1218395A Buccal delivery system
06/02/1999CN1218050A Sulfonamide-substituted benzopyran derivates processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
06/02/1999CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
06/02/1999CN1218044A Urea derivatives
06/02/1999CN1043532C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
06/01/1999US5908851 Derivatives of succinamide and their use as metalloproteinase inhibitor
06/01/1999US5908837 Antiinflammatory agent
06/01/1999US5908833 Glucocorticosteroid chemically bound to a sugar
06/01/1999US5908636 Polyalkylene glycol having an average molecular weight of about 400 to about 20,000
06/01/1999US5908626 Genetic engineering
05/1999
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025711A1 New process
05/27/1999WO1999025710A1 Imidazole derivatives, preparation and therapeutic application thereof
05/27/1999WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999WO1999025686A1 Cyclic amine derivatives and their use as drugs
05/27/1999WO1999025357A1 USE OF 9-DEOXY-2', 9-α-METHANO-3- OXA-4,5,6- TRINOR-3, 7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F1 TO TREAT PERIPHERAL VASCULAR DISEASE
05/27/1999WO1999025348A1 5-ht1f agonists
05/27/1999WO1999025323A1 Omeprazole formulation
05/27/1999WO1999018952B1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999012933A3 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/27/1999CA2310248A1 5-ht1f agonists
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999CA2276753A1 New process
05/26/1999EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
05/26/1999EP0917878A1 Remedies for hepatitis
05/26/1999EP0752991B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
05/26/1999CN1217660A Method for retreatment of patients afflicted with Hepatitis C using consensus interferon
05/26/1999CN1217657A Nasal administration of agents for treatment of delayed onset emesis
05/25/1999US5906991 Releasing and absorption, suspension and heating
05/25/1999US5906811 Reducing free radical damage by tobacco or environmental pollutants administering a mixture of glutathione, ascorbic acid, selenium or selenium compound, a sulphur containing amino acid, as mouthwashes, mouth sprayer, nasal inhaler
05/25/1999CA2111178C Food composition
05/20/1999WO1999024576A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999WO1999024470A1 Mammalian milk growth factor
05/20/1999WO1999024423A1 Piperidine derivatives and their use as tachykinin antagonists
05/20/1999WO1999024421A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
05/20/1999WO1999024419A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024416A1 Aminothiazole inhibitors of cyclin dependent kinases
05/20/1999WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999WO1999024406A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
05/20/1999WO1999024405A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
05/20/1999WO1999024404A1 Substituted pyridine compounds as anti-inflammatory agents
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
1 ... 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 ... 1258